Good Recover with some volume. The company fundamental is decent. The vaccine maybe should be a good catalyst for this stock in the mid-term.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
